Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
25.62
-0.19 (-0.74%)
Apr 30, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Hemorrhoid Products | 1.29B |
Log In |
Log In |
Log In |
Log In |
Hemorrhoid Products Growth | -13.18% |
Log In |
Log In |
Log In |
Log In |
Pharmaceutical | 1.09B |
Log In |
Log In |
Log In |
Log In |
Pharmaceutical Growth | -19.67% |
Log In |
Log In |
Log In |
Log In |
Other Products | 542.30M |
Log In |
Log In |
Log In |
Log In |
Other Products Growth | -7.31% |
Log In |
Log In |
Log In |
Log In |
Medical Services | 344.76M |
Log In |
Log In |
Log In |
Log In |
Medical Services Growth | 33.28% |
Log In |
Log In |
Log In |
Log In |
Other Business | 38.30M |
Log In |
Log In |
Log In |
Log In |
Other Business Growth | 9.08% |
Log In |
Log In |
Log In |
Log In |
Internal Offset | -168.50M |
Log In |
Log In |
Log In |
Log In |
Internal Offset Growth | -10.76% |
Log In |
Log In |
Log In |
Log In |
Retail and Wholesale | - |
Log In |
Log In |
Log In |
Log In |
Retail and Wholesale Growth | - |
Log In |
Log In |
Log In |
Log In |
Other Business Income Internal Elimination | - |
Log In |
Log In |
Log In |
Log In |
Other Business Income Internal Elimination Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
China | 3.13B |
Log In |
Log In |
Log In |
Log In |
China Growth | -11.26% |
Log In |
Log In |
Log In |
Log In |
International | 4.18M |
Log In |
Log In |
Log In |
Log In |
International Growth | 74.71% |
Log In |
Log In |
Log In |
Log In |